James A. Whitlock

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

Kathryn G. Roberts, Yongjin Li, Debbie Payne-Turner et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text

Life Sciences, Genetics, Oncology +17

Long-Term Follow-up of Asymptomatic Healthy Subjects with Frequent and Complex Ventricular Ectopy

Harold L. Kennedy, James A. Whitlock, Michael K. Sprague et al. · New England Journal of Medicine · 1985 · 636 citations

Medicine, Cardiology, Internal Medicine +16

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2016 · 605 citations · Full text

Medicine, Hematology, Oncology +17

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia

Patrick A. Brown, Lingyun Ji, Xinxin Xu et al. · JAMA · 2021 · 361 citations · Full text

Medicine, Hematology, Oncology +17

Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’s Oncology Group

Stacey L. Berg, Susan M. Blaney, Meenakshi Devidas et al. · Journal of Clinical Oncology · 2005 · 321 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15